Twist Bioscience Co. (NASDAQ:TWST) Director Robert Chess Sells 4,110 Shares

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) Director Robert Chess sold 4,110 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $34.98, for a total value of $143,767.80. Following the completion of the transaction, the director now directly owns 64,169 […]

Related Keywords

China , ,Nasdaq ,Us Bancorp ,Twist Bioscience Corporation ,Edgerock Capital ,Scotiabank ,Goldman Sachs Group ,China Universal Asset Management Co ,Barclays ,Securities Exchange Commission ,Hermes Inc ,Twist Bioscience Co ,Twist Bioscience Company Profile ,Twist Bioscience ,Get Free Report ,Director Robert Chess ,Exchange Commission ,Financial Advisors ,Universal Asset Management ,Rock Capital ,Bioscience Corporation ,Twist Bioscience Daily ,Nasdaq Twst ,Twst ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,